...
首页> 外文期刊>Neurosurgery >Endothelial cell activation after subarachnoid hemorrhage.
【24h】

Endothelial cell activation after subarachnoid hemorrhage.

机译:蛛网膜下腔出血后内皮细胞活化。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Evidence from animal experiments suggests that endothelial cell activation plays a pathogenetic role in the development of cerebral ischemia after subarachnoid hemorrhage (SAH). We measured plasma concentrations of two markers of endothelial cell activation, i.e., ED1-fibronectin (ED1-fn) and von Willebrand factor (vWf), among patients with aneurysmal SAH. We analyzed the relationships of concentrations to initial clinical conditions, treatment modalities, and the occurrence of delayed cerebral ischemia. METHODS: We collected 123 blood samples from 27 patients with aneurysmal SAH. Aneurysms were treated surgically in 19 cases, were treated endovascularly in 7 cases, and remained untreated in 1 case. Twelve patients developed symptomatic delayed cerebral ischemia. RESULTS: Initial concentrations of ED1-fn (4.3 +/- 3.7 microg/ml) and vWf (17.8 +/- 8.2 microg/ml) were higher than the reference values (ED1-fn, 1.7 +/- 0.9 microg/ml, P < 0.001; vWf, 11.5 +/- 5.2 microg/ml, P = 0.003). Concentrations were higher among patients in poor clinical condition at admission, compared with patients in good clinical condition (mean difference, ED1-fn, 5.7 microg/ml, P = 0.04; vWf, 10.4 microg/ml, P = 0.02). Levels of both markers increased significantly after surgery (mean increase, ED1-fn, 7.5 microg/ml, P = 0.01; vWf, 13.2 microg/ml, P = 0.05) and after ischemic episodes (mean increase, ED1-fn, 8.3 microg/ml, P = 0.02; vWf, 5.0 microg/ml, P = 0.04). CONCLUSION: Plasma concentrations of markers of endothelial cell activation were increased early after SAH and were significantly associated with the clinical condition at admission. We also observed a significant increase in concentrations after surgery and after ischemic episodes. Whether endothelial cell activation is a causal or indirectly related factor in the pathogenesis of delayed cerebral ischemia after SAH is still uncertain.
机译:目的:动物实验的证据表明,内皮细胞活化在蛛网膜下腔出血(SAH)后脑缺血的发展中具有致病作用。我们在患有动脉瘤的SAH患者中测量了两种内皮细胞激活标志物的血浆浓度,即ED1-纤连蛋白(ED1-fn)和von Willebrand因子(vWf)。我们分析了浓度与初始临床状况,治疗方式和迟发性脑缺血的关系。方法:我们从27例动脉瘤性SAH患者中收集了123份血液样本。手术治疗动脉瘤19例,血管内治疗7例,未治疗1例。 12名患者出现症状性迟发性脑缺血。结果:ED1-fn(4.3 +/- 3.7 microg / ml)和vWf(17.8 +/- 8.2 microg / ml)的初始浓度高于参考值(ED1-fn,1.7 +/- 0.9 microg / ml, P <0.001; vWf,11.5 +/- 5.2 microg / ml,P = 0.003)。与临床状况良好的患者相比,入院时临床状况较差的患者中的浓度更高(平均值差异,ED1-fn为5.7 microg / ml,P = 0.04; vWf为10.4 microg / ml,P = 0.02)。手术后和缺血发作后,两种标志物的水平均显着升高(平均升高,ED1-fn,7.5 microg / ml,P = 0.01; vWf,13.2 microg / ml,P = 0.05),并且缺血发作后(平均升高,ED1-fn,8.3 microg) /ml,P=0.02;vWf,5.0μg/ml,P=0.04)。结论:SAH后早期内皮细胞激活标志物的血浆浓度升高,并且与入院时的临床状况显着相关。我们还观察到手术后和缺血发作后血药浓度显着增加。在SAH后延迟性脑缺血的发病机制中,内皮细胞激活是因果还是间接相关因素尚不确定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号